Cargando…
Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs
BACKGROUND: Limited resources and expanding expectations push all countries and types of health systems to adopt new approaches in priority setting and resources allocation. Despite best efforts, it is difficult to reconcile all competing interests, and trade-offs are inevitable. This is why multi-c...
Autores principales: | Iskrov, Georgi, Miteva-Katrandzhieva, Tsonka, Stefanov, Rumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042964/ https://www.ncbi.nlm.nih.gov/pubmed/27747207 http://dx.doi.org/10.3389/fpubh.2016.00214 |
Ejemplares similares
-
Health Economic Data in Reimbursement of New Medical Technologies: Importance of the Socio-Economic Burden as a Decision-Making Criterion
por: Iskrov, Georgi, et al.
Publicado: (2016) -
Prospects of Risk-Sharing Agreements for Innovative Therapies in a Context of Deficit Spending in Bulgaria
por: Iskrov, Georgi, et al.
Publicado: (2015) -
Whole-Genome Sequencing in Newborn Screening—Attitudes and Opinions of Bulgarian Pediatricians and Geneticists
por: Iskrov, Georgi, et al.
Publicado: (2017) -
Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
por: Ignatova, Valentina, et al.
Publicado: (2022) -
Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review
por: Raycheva, Ralitsa, et al.
Publicado: (2023)